Bank Julius Baer & Co
ATNM icon

Bank Julius Baer & Co’s Actinium Pharmaceuticals ATNM Stock Holding History

Bank Julius Baer & Co’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,028
Closed -$18K – 600
2021
Q4 		$18K Sell
3,028
-5,805
-66% -$43.5K ﹤0.01% 746
2021
Q3 		$78K Buy
8,833
+5,040
+133% +$35.1K ﹤0.01% 644
2021
Q2 		$30K Buy
3,793
+945
+33% +$7.42K ﹤0.01% 726
2021
Q1 		$22K Sell
2,848
-1,255
-31% -$10.7K ﹤0.01% 741
2020
Q4 		$32K Sell
4,103
-1,028
-20% -$11.2K ﹤0.01% 724
2020
Q3 		$50K Sell
5,131
-6,351
-55% -$70K ﹤0.01% 602
2020
Q2 		$120K Buy
11,482
+3,436
+43% +$26K ﹤0.01% 512
2020
Q1 		$47K Buy
+8,046
New +$57.2K ﹤0.01% 548

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank Julius Baer & Co's ATNM Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Actinium Pharmaceuticals (ATNM) in Q1 2022, closing a stake of 3,028 shares — an estimated $18K sold.

Bank Julius Baer & Co first reported a position in ATNM in Q1 2020 and held it in 8 quarters. The position peaked at $120K in Q2 2020. 38 funds tracked by Wall St. Rank hold ATNM as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Actinium Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 3,028 Actinium Pharmaceuticals shares in Q1 2022, an estimated $18K.
  • Bank Julius Baer & Co first reported a position in Actinium Pharmaceuticals in Q1 2020 and held it in 8 quarters.
  • Bank Julius Baer & Co's Actinium Pharmaceuticals position peaked at $120K in Q2 2020.
  • 38 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.